Primary Human Cells
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $25,000 to $250,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Points of contact
-
- tbd@fda.gov
- Joshua Holliday joshua.holliday@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Department of Health and Human Services Food and Drug Administration (FDA) is forecasting a procurement for primary human trophoblast cells to support research at the Perinatal Health Center of Excellence (PHCE). The estimated solicitation will be released on February 1, 2026, with an anticipated contract award date of April 1, 2026. This procurement falls under the NAICS category 541990 for All Other Professional, Scientific, and Technical Services.
While specific award values and budget ranges are not currently available, the contract will involve the procurement of primary human cells for specialized scientific research. The point of contact for this opportunity is Joshua Holliday, who can be reached at joshua.holliday@fda.hhs.gov within the FDA organization. Potential vendors should note this is a non-set-aside contract, and interested parties can expect further details to be disclosed closer to the solicitation release date in early 2026.
Forecast text
Primary human trophoblast cells required to support Perinatal Health Center of Excellence (PHCE) funded research.
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast